Daunorubicin interactions
Daunorubicin (Cerubidine) has 6 documented interactions across the FDA labels and fact sheets we index: 1 major, 5 moderate, 0 minor, and 0 where a label reports no significant interaction. Each entry below quotes the sentence behind it. This drug page is a starting point, not a verdict for your situation.
Interactions from the label
Major interactions (1)
- DoxorubicinMajor
Daunorubicin hydrochloride should not be used in patients who have previously received the recommended maximum cumulative doses of doxorubicin or daunorubicin hydrochloride. (Daunorubicin label, Drug interactions)
Moderate interactions (5)
- BortezomibModerate
In a clinical trial, the first two patients given high-dose cytarabine (2 g/m 2 per day) by continuous infusion with daunorubicin and bortezomib for relapsed acute myelogenous leukemia died of ARDS early in the course of therapy. (Bortezomib label, Warnings and precautions)
Cyclophosphamide used concurrently with daunorubicin hydrochloride may also result in increased cardiotoxicity. (Daunorubicin label, Drug interactions)
Anthracycline Antibiotics High doses of cyclosporine (e.g., at starting intravenous dose of 16 mg/kg/day) may increase the exposure to anthracycline antibiotics (e.g., doxorubicin, mitoxantrone, daunorubicin) in cancer patients. (Cyclosporine label, Drug interactions)
Hepatotoxic medications, such as high-dose methotrexate, may impair liver function and increase the risk of toxicity. (Daunorubicin label, Drug interactions)
- MitoxantroneModerate
Cardiac Effects Because of the possible danger of cardiac effects in patients previously treated with daunorubicin or doxorubicin, the benefit-to-risk ratio of mitoxantrone injection therapy in such patients should be determined before starting therapy. (Mitoxantrone label, Warnings)
Check Daunorubicin against everything you take. Add your full list; every pair is checked at once.
Open in the checkerNot medical advice. Severity reflects the label's wording, not your circumstances. A "major" flag can be routine under supervision and a "minor" one can matter at high doses. Ask a pharmacist.